- Joined
- 27 December 2010
- Posts
- 1,729
- Reactions
- 48
Pretty convinced that DVL is more complementary to CAT than a competitor. CAT is definitely an "in-game" product whereas DVL looks like it is more used for rehab and "back-to-play" decisions.Has anyone looked into dorsaVI (DVL). Looks like a potential competitor to CAT.
Q2 and Q3 have now both exceeded last year's Q4, a first. Q3 has also exceeded Q2, again a first. I was looking for explosive growth and it appears to be starting. The target of 8,000, set in March, has a pretty good chance of being beaten on the current momentum, imo.
VSntchr said:Subscription units now 57% up from 51% PCP
Summary of the deal:
The XOS Acquisition is expected to be substantially accretive to Catapult’s total revenues, recurring revenue base, and earnings before interest, taxes, depreciation and amortisation (“EBITDA”) pre-synergies, and will accelerate Catapult’s transition to positive EBITDA and free cash flow in FY17. XOS is expected to deliver US$25.0 million (A$34.3 million) in revenue, US$19.6 million (A$27.0 million) in annualised recurring revenue (“ARR”), and US$6.0 million (A$8.3 million) in EBITDA5 in the 12 months to 30 June 2016 (“FY16”).6 The acquisition price implies a transaction multiple of 2.4x FY16 revenue and 10.0x FY16 EBITDA.
Further financial guidance announced today:
As released to the market on 5 July, Catapult upgrades its full year FY16 guidance for units ordered to 8,354 and total contract value (“TCV”) to $29.4 million. Today Catapult also advises that it expects to achieve revenue of A$18.0 to 19.0 million, annual recurring revenue (“ARR”) of A$13.0 to 14.0 million and EBITDA of A$(3.8) to (4.8) million4 for FY16.
Discloser, happy long-term holder. Will be topping up on the cap raising and will be sending more money with the hope they accept it
I am surprised how cheap the acquisition is... looking at some of the metrics based on the transaction price and CAT's last market cap of $194m.
Market cap / revenue XOS = 2.4x, CAT = 10.5x
Market cap / ARR XOS = 3.0x, CAT = 14.4x
Market cap / EBITDA XOS = 10.0x, CAT = N/A
Perhaps XOS is just a big data IT firm (where there are many alternatives) while CAT's products have more unique IP?
It's even cheaper. CAT's MC is ~$450m.
XOS is a much more mature business than CAT, from what I gather. I wouldn't expect the enlarged CAT to trade on the same revenue multiple as CAT currently does. That being said, I think it's a very shrewd investment. They've already been working with XOS since early last year (with the Jacksonville Jaguars combing the two techs) so they probably already have some idea of where they can cross sell either product.XOS also has licensing agreements with media outlets in the US which CAT has been talking up as the way forward. Video with wearable puts them well ahead of anyone else, especially given how good CAT's existing wearables stuff is.
Also had a quick look at PlayerTek's website. Prosumer is going to be a great market. Although it is probably going have a lot more competition given the alternatives out there. I think most fitness bands have GPS and are good enough for sports like running and cycling. But sports like football and soccer requiring more accurate tracking will still need the better hardware.
Perhaps the analytics and pro-comparison would be unique selling points available to CAT.
P.S. Bell Potter's been pushing this cat hard recently and now we know why...
Any thoughts?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?